Structures by: Šafář P.
Total: 17
C13H13NO
C13H13NO
Organic letters (2017) 19, 18 4742-4745
a=19.0876(9)Å b=6.1438(4)Å c=8.6807(4)Å
α=90° β=97.141(4)° γ=90°
C13H11NO
C13H11NO
Organic letters (2017) 19, 18 4742-4745
a=21.9487(9)Å b=6.8730(3)Å c=12.8765(5)Å
α=90° β=91.458(3)° γ=90°
C12H11NO
C12H11NO
Organic letters (2017) 19, 18 4742-4745
a=6.8948(4)Å b=18.3370(9)Å c=7.3727(5)Å
α=90° β=109.637(5)° γ=90°
C12H16NO51,Br1,H2O1
C12H16NO51,Br1,H2O1
Acta Crystallographica Section E (2001) 57, 8 o775-o777
a=8.72530(10)Å b=8.92710(10)Å c=11.5975(2)Å
α=72.680(10)° β=71.250(10)° γ=61.010(10)°
(11<i>R</i>,11aS)-11-Hydroxy-1,5,11,11a-tetrahydro- 1-benzothieno[2,3-<i>f</i>]indolizin-3(2<i>H</i>)-one
C14H13NO2S
Acta Crystallographica Section E (2008) 64, 6 o1164-o1165
a=7.66140(10)Å b=11.7733(2)Å c=13.0736(2)Å
α=90.00° β=90.00° γ=90.00°
(8aS)-8,8a-Dihydrofuro[3,2-f]indolizine-6,9(4H,7H)-dione
C10H9NO3
Acta Crystallographica Section E (2007) 63, 7 o3180-o3181
a=6.87710(10)Å b=7.21980(10)Å c=17.7271(2)Å
α=90.00° β=90.00° γ=90.00°
(<i>S</i>)-6-Oxo-1-(thiophen-2-ylmethyl)piperidine-2-carboxylic acid
C11H13NO3S
Acta Crystallographica Section C (2014) 70, 8 817-822
a=5.3473(11)Å b=13.073(2)Å c=8.408(5)Å
α=90.00° β=103.88(3)° γ=90.00°
(7<i>R</i>,8<i>S</i>,8a<i>S</i>)-8-Hydroxy-7-phenylperhydroindolizin-3-one
C14H17NO2
Acta Crystallographica Section E (2009) 65, 6 o1368-o1369
a=11.4164(3)Å b=6.6372(2)Å c=15.5118(4)Å
α=90.00° β=90.00° γ=90.00°
(8aS)-7,8,8a,9-tetrahydrothieno[3,2-<i>f</i>]indolizin-6(4<i>H</i>)-one
C10H11NOS
Acta Crystallographica Section E (2009) 65, 4 o695-o696
a=6.37912(16)Å b=8.3654(3)Å c=9.0715(3)Å
α=84.180(3)° β=78.611(2)° γ=76.174(3)°
(6<i>S</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-6-Ethyl-7,8- dihydroxy-1,5,6,7,8,8a-hexahydroindolizin-3(2<i>H</i>)-one monohydrate
C10H17NO3,H2O
Acta Crystallographica Section E (2010) 66, 12 o3112-o3113
a=7.1398(3)Å b=7.3169(2)Å c=20.8466(9)Å
α=90.00° β=90.00° γ=90.00°
(4<i>R</i>,6<i>S</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-6-Ethyl-7,8-dihydroxy- 4-methyl-1,2,3,5,6,7,8,8a-octahydroindolizin-4-ium iodide
C11H22NO2,I
Acta Crystallographica Section E (2011) 67, 12 o3520-o3521
a=8.18603(14)Å b=10.82977(14)Å c=8.19874(13)Å
α=90.00° β=110.3688(19)° γ=90.00°
(8a<i>RS</i>)-8,8a-Dihydrofuro[3,2-<i>f</i>]indolizine- 6,9(4<i>H</i>,7<i>H</i>)-dione
C10H9NO3
Acta Crystallographica Section E (2011) 67, 8 o2035
a=7.63534(19)Å b=11.7583(2)Å c=9.9234(3)Å
α=90.00° β=105.775(3)° γ=90.00°
(6<i>S</i>,7<i>S</i>,8<i>S</i>,8a<i>S</i>)-6-Ethyl-3-oxo- 1,2,3,5,6,7,8,8a-octahydroindolizine-7,8-diyl diacetate
C14H21NO5
Acta Crystallographica Section E (2012) 68, 3 o662-o663
a=11.5157(2)Å b=9.82390(10)Å c=14.0922(2)Å
α=90.00° β=99.035(2)° γ=90.00°
(8a<i>R</i>,9<i>R</i>)-9-Hydroxy-7,8,8a,9- tetrahydrofuro[3,2-<i>f</i>]indolizin-6(4<i>H</i>)-one
C10H11NO3
Acta Crystallographica Section E (2012) 68, 10 o3034-o3035
a=14.7603(10)Å b=15.1301(17)Å c=16.2847(9)Å
α=90.00° β=90.00° γ=90.00°
(5<i>S</i>,11a<i>S</i>)-5-Hydroperoxy-1,5,11,11a- tetrahydro[1]benzothieno[3,2-<i>f</i>]indolizin-3(2<i>H</i>)-one
C14H13NO3S
Acta Crystallographica Section E (2012) 68, 12 o3327-o3328
a=7.8040(5)Å b=7.9800(4)Å c=10.2903(5)Å
α=90.00° β=99.458(5)° γ=90.00°
(11a<i>S</i>)-1,5,11,11a-Tetrahydro-1-benzothieno[3,2-<i>f</i>]indolizin-3(2<i>H</i>)-one
C14H13NOS
Acta Crystallographica Section E (2013) 69, 12 o1819-o1820
a=9.3327(8)Å b=12.4575(7)Å c=10.3103(7)Å
α=90.00° β=105.469(8)° γ=90.00°
(<i>S</i>)-6-Oxo-1-(thiophen-3-ylmethyl)piperidine-2-carboxylic acid
C11H13NO3S
Acta Crystallographica Section C (2014) 70, 8 817-822
a=7.9560(4)Å b=10.3710(5)Å c=13.8612(6)Å
α=90.00° β=90.00° γ=90.00°